-

Moxie Health Group Hosts First-Ever Moxiethon Hackathon in Honduras, Uniting Students to Innovate the Future of Healthcare

Three-day event brought together top university students to design AI-driven solutions for real-world healthcare challenges, marking a milestone in Moxie Health’s mission to bridge technology and patient care.

SAN PEDRO SULA, Honduras--(BUSINESS WIRE)--The Moxie Health Group hosted its inaugural Moxiethon Hackathon, a three-day innovation challenge uniting more than 50 computer science students from leading Honduran universities to develop healthcare technology solutions using the company’s proprietary platform, Moxie-Link.

Moxiethon was about empowering young technologists to bridge innovation with compassion—connecting data, caregivers, and patients to make care more human and effective.

Share

Held from September 25–27, the event centered on the theme “AI in Healthcare,” challenging participants to identify real-world issues in patient care and propose solutions to improve outcomes and efficiency. Students formed interdisciplinary teams, attended workshops, and collaborated with mentors across healthcare and technology sectors.

“This hackathon was about more than coding,” said Dr. Gustavo Ferrer, Founder and CEO of The Moxie Health Group and Dr. Ferrer BioPharma. “It was about empowering young technologists in Honduras to design solutions that bridge innovation with compassion—connecting data, caregivers, and patients in ways that make care more human and effective.”

Event Highlights

Throughout the weekend, participants transformed ideas into impact—beginning with networking and team-building sessions that encouraged creativity and collaboration. They explored Moxie Health’s mission and the capabilities of Moxie-Link, an operational excellence platform connecting care teams through real-time data and performance insights.

Guided by Moxie Health engineers and physicians, teams developed solutions during interactive workshops such as “Building AI for Better Care” and “Perfecting Your Pitch.” The hackathon concluded with live demos before a panel of judges who evaluated innovation, impact, and execution.

The winning team — Roberto Carlos Garay Logan and Luis Fernando Bautista Castellanos — created an automated system that analyzes calls between on-call agents and facility nurses, generating real-time summaries sent directly to the appropriate nurse practitioner’s device. The system will be integrated into Moxie-Link to improve communication efficiency and patient care coordination.

Innovation with Impact

“Moxiethon reflects our commitment to innovation and community development,” said Dr. Alfonso Ortega, Chief Technology Officer at MoxieLink. “By engaging local talent, we’re enhancing Moxie-Link’s capabilities while giving young engineers the chance to shape the future of healthcare technology.”

The winning team will continue developing their project within Moxie Health, advancing the company’s mission to improve long-term respiratory and patient care outcomes.

Looking ahead, Moxie Health plans to expand Moxiethon 2026 to include more participants and new challenges in digital health, data analytics, and AI-driven care.

About The Moxie Health Group

Moxie Health is redefining long-term respiratory care through clinical excellence and data-driven innovation. Its pulmonary and critical care team improves outcomes in nursing homes by reducing readmissions, empowering staff, and delivering evidence-based care through its real-time data platform, Moxie-Link.

About Dr. Ferrer BioPharma

Dr. Ferrer BioPharma develops advanced respiratory treatments that help people “Breathe Better.” Combining science and compassion, the company creates therapies that prevent complications, enhance outcomes, and advance the future of respiratory health.

Contacts

Amanda Ferrer
Marketing Director
+1-954-904-1773
marketing@pulmonary-institute.com

Dr. Ferrer BioPharma


Release Summary
Moxie Health hosts first MoxieThon Hackathon in Honduras, uniting students to develop AI-driven healthcare solutions through Moxie-Link.
Release Versions

Contacts

Amanda Ferrer
Marketing Director
+1-954-904-1773
marketing@pulmonary-institute.com

Social Media Profiles
More News From Dr. Ferrer BioPharma

ClorNovir by Dr. Ferrer BioPharma Named Finalist at CPHI Pharma Awards 2024 for Breakthrough COVID-19 and Post-COVID Care

MILAN--(BUSINESS WIRE)--ClorNovir by Dr. Ferrer BioPharma is a CPHI Pharma Awards 2024 finalist for its innovative COVID-19 and post-COVID care nasal spray solution....

Dr. Ferrer BioPharma Awarded Winner at CPHI Pharmapack 2024 for Groundbreaking GentleMist Technology

PARIS--(BUSINESS WIRE)--Marking a milestone in pharmaceutical innovation and excellence, Dr. Ferrer BioPharma has been honored with a prestigious award at the renowned CPHI Pharmapack 2024, which took place at the Paris Expo, Porte de Versailles. The company’s groundbreaking GentleMist Technology received the "Patient-Centric Design" award, highlighting its revolutionary approach in intranasal drug delivery. The GentleMist Technology represents a paradigm shift in the administration of medicati...

Dr. Ferrer BioPharma Named Finalist for CPhI Pharma Awards 2023

HALLANDALE BEACH, Fla.--(BUSINESS WIRE)--Dr. Ferrer BioPharma (DFB) is honored to be a finalist for the prestigious CPhI Pharma Worldwide Awards 2023, an internationally renowned award platform organized by CPhI, the world's leading pharmaceutical networking event. DFB has achieved consecutive recognition as a finalist for three years running: in 2021, they were acknowledged for their Innovation in Response to COVID-19; in 2021 and 2022, they were finalists in the Finished Formulation category;...
Back to Newsroom